Specialist Women's Imaging Centre streamlines detection
THE LASZLO Tabar Breast Centre at the Specialist Women's Imaging Centre has added a powerful diagnostic tool to help physicians reach definitive diagnoses of the presence or absence of breast cancer.
With SenoBright Contrast-Enhanced Spectral Mammography (CESM) from GE Healthcare, physicians have the potential to reach definitive decisions sooner-and cut the critical patient wait time from detection to diagnosis.
"For a woman facing even the slightest hint of a breast cancer diagnosis, the answers can't come soon enough," SWIC's consultant radiologist, Dr Sean O'Connor said.
"With SenoBright, we can have the answers right here, right now."
Performed as an adjunct to an inconclusive mammography or ultrasound exam, SenoBright uses an iodine contrast agent (x-ray dye) to highlight areas of unusual blood flow patterns which may be cause for increased suspicion.
The SenoBright exam is a simple, quick, five-to-ten-minute procedure that's much like a regular mammography exam, with the injection of a small amount of the iodine contrast agent beforehand.
It can be performed on the same day as standard mammography, using the same equipment, in the same room, often with the same staff.
It takes one injection for one complete bi-lateral exam-and four views that can mean all the difference to a woman concerned about a breast cancer diagnosis.
"With SenoBright, we can perform an additional test right away," Dr O'Connor said.
"We use the same equipment, in the same room, often with the same staff, and we can even do it on the same day.
"SenoBright requires one injection for a complete set of images.
"That's all it takes for us to help reduce the wonder and the worry of a concerned patient waiting for results," Dr O'Connor adds.
How does it work?
To understand that, we have to learn about something that happens during cancer development.
In a very early phase of tumor development cancers do not have their own blood supplies. However, as cancerous tumors begin to grow, a dedicated blood supply is required. The use of contrast agents can highlight the presence of high blood flow patterns.
SenoBright is based on what we call Contrast Enhanced Spectral Mammography (CESM). It uses X-rays at multiple energies to create two separate exposures.
These different energies result in images that specifically highlight areas where contrast agents are, which can be a sign used by physicians to heighten their suspicion.
Women with inconclusive mammography and ultrasound exams will receive a standard intravenous injection of standard iodine contrast agent, and after two minutes undergo a five-minute digital mammography exam.
Technological Leadership with SenoBright:
SenoBright Value Proposition
- Increased diagnostic confidence, improved patients' experience, reduced diagnostic costs.
- SenoBright is an advanced application designed to help radiologists enhance their breast care pathway.
Increased diagnostic confidence
- SenoBright has better breast cancer detection performance than standard mammography and sensitivity is increased by up to 20% in dense breasts.
Improved patients' experience
- Radiologists can reduce their patients' anxiety by offering them a SenoBright exam at the same time, same location with the same equipment,
Reduced diagnostic costs
- With similar clinical performances as breast MRI & better specificity (+5%), SenoBright helps to reduce unnecessary biopsies & surgeries and is a less expensive exam.
International Clinical claims
SenoBright vs standard Mammography
- CESM has better Breast Cancer detection performance than standard mammography.
- CESM significantly increases the specificity which helps eliminate false positives observed in conventional mammography.
SenoBright in Dense Breasts
- Sensitivity increases up to 20% with CESM in dense breasts compared to conventional mammography.
- Compared to conventional mammography, CESM reduces inter-reader variability.